Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 5,996 | 7,610 | 6,226 | 6,480 | 6,382 |
| Operating Income | -5,996 | -7,610 | -6,226 | -6,480 | -6,382 |
| Other Income | 190 | 61 | 22 | 72 | 70 |
| Pre-tax Income | -5,806 | -7,549 | -6,204 | -6,408 | -6,312 |
| Net Income Continuous | -5,806 | -7,549 | -6,204 | -6,408 | -6,312 |
| Net Income | $-5,806 | $-7,549 | $-6,204 | $-6,408 | $-6,312 |
| EPS Basic Total Ops | 1,683.05 | -40.11 | -151.08 | -1,579.14 | 129,673.20 |
| EPS Basic Continuous Ops | 1,683.36 | -33.53 | -151.17 | -1,580.96 | 129,673.80 |
| EPS Diluted Total Ops | 1,683.05 | -40.11 | -151.08 | -1,579.14 | 129,673.20 |
| EPS Diluted Continuous Ops | 1,683.36 | -33.53 | -151.17 | -1,580.96 | 129,673.80 |
| EPS Diluted Before Non-Recurring Items | N/A | -40.11 | -151.08 | -1,579.14 | N/A |
| EBITDA(a) | $-5,915 | $-7,561 | $-6,177 | $-6,419 | $-6,311 |